Sanara MedTech Inc

SMTI USD0.001
Create an alert
Sell$35.10
Buy$35.11
$0.01 (0.03%)
Last updated today at
Back to dashboard

Company Information

About this company

Sanara MedTech Inc. is a medical technology company focused on developing and commercializing transformative technologies to improve clinical outcomes and reduce healthcare expenditures in the surgical markets. It primarily markets and sells soft tissue repair and bone fusion products for use in the operating room or other sterile environments. Its soft tissue repair products include, among other products, the lead product, CellerateRX Surgical Powder, a hydrolyzed collagen that aids in the management of surgical wounds, BIASURGE Advanced Surgical Solution, a sterile no-rinse, advanced surgical solution used for wound irrigation and TEXAGEN Amniotic Membrane Allograft, a multi-layer amniotic membrane allograft used as an anatomical barrier with robust handling that can be sutured for securement if needed. Its bone fusion products include, among other products, BiFORM Bioactive Moldable Matrix, ACTIGEN Verified Inductive Bone Matrix, and ALLOCYTE Plus Advanced Viable Bone Matrix.

Key people

Ronald T. Nixon
Executive Chairman of the Board
Seth D. Yon
President, Chief Executive Officer, Director
Elizabeth B. Taylor
Chief Financial Officer
Jacob A. Waldrop
Chief Operating Officer
Ann Beal Salamone
Director
Robert A. Desutter
Independent Director
Roszell Mack
Independent Director
Eric D. Major
Independent Director
Keith G. Myers
Independent Director
Click to see more

Key facts

  • Shares in issue
    9.19m
  • EPIC
    SMTI
  • ISIN
    US79957L1008
  • Location
    United States
  • Sector
    Healthcare
  • Industry
    Biotechnology & Drugs
  • Market cap
    $322.87m
  • Employees
    108
  • Exchange
    NASDAQ
  • Index

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Overview data is sourced from Refinitiv.